Keyphrases
Surfactant Protein A (SP-A)
100%
Child Hospitalized
100%
Protein Variants
100%
Respiratory Syncytial Virus
100%
Surfactant Protein D (SP-D)
66%
Virus Diseases
66%
Surfactant Protein A2
33%
Single nucleotide Polymorphism
33%
Clinical Trials
16%
Transmission Disequilibrium Test
16%
Patient Demographics
16%
Genetic Variation
16%
Genomic DNA (gDNA)
16%
At-risk
16%
Acute Infection
16%
Lung Injury
16%
Familial Relationships
16%
Clinical High Risk
16%
Respiratory Syncytial Virus Infection
16%
Pharmacology, Toxicology and Pharmaceutical Science
Surfactant
100%
Human Respiratory Syncytial Virus
100%
Protein Variant
100%
Disease
66%
Surfactant Protein D
66%
Surfactant Protein A
50%
Clinical Trial
16%
Symptom
16%
Infection
16%
Genomic DNA
16%
Respiratory Syncytial Virus Infection
16%
Biochemistry, Genetics and Molecular Biology
Haplotype
100%
Surfactant Protein
100%
Human Respiratory Syncytial Virus
100%
Surfactant Protein D
57%
Surfactant Protein A
42%
Progeny
28%
Single-Nucleotide Polymorphism
28%
Transmission Disequilibrium Test
14%
Genetic Variation
14%
Clinical Trial
14%
Immunology and Microbiology
Haplotype
100%
Human Respiratory Syncytial Virus
100%
Surfactant Protein D
66%
Surfactant Protein A
50%
Progeny
33%
Single Nucleotide Polymorphism
33%
Genetic Variation
16%
Respiratory Syncytial Virus Infection
16%